Feasibility of a Therapist-Supported Digital Mental Health Intervention in Addressing Mental Health Symptoms Among People With Cancer: A Mixed Methods Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 2
- 主要终点
- Change in PHQ-9 Scores
研究概览
简要总结
The primary objective of this study is to evaluate clinical outcomes among people with cancer who participate in a 12-week therapist-supported digital mental health intervention (DMHI) called the Meru Health Program (MHP). Study participants (N=20) will be referred to the MHP through the Cancer Support Community (CSC) Helpline and network of Gilda's Club locations. The main outcomes will be depression symptoms, anxiety symptoms, health-related quality of life (HRQoL), intervention adherence, and intervention satisfaction. The secondary objective will be to determine the acceptability of the screening and referral process from the CSC networks into the MHP. Data pertaining to implementability will be collected from study participants, MHP clinicians, and CSC staff.
详细描述
The goal of this single-arm intervention study is to test the feasibility of the Meru Health Program (MHP) in reducing symptoms of depression and anxiety among 20 people with cancer referred from the Cancer Support Community (CSC). The MHP is a 12-week digital mental health intervention delivered via a smartphone app. The intervention focuses on cognitive behavioral techniques and mindfulness skills with the aim of improving mental health symptoms. The platform provides informational videos, skills practices, group discussion, and messaging with a licensed clinician employed by Meru Health. The licensed clinician supports patients as needed and reviews engagement logs within the app. As part of the intervention, depression and anxiety symptoms are measured on a biweekly basis over 12 weeks. For this study, self-reported surveys will be administered at baseline, week 12, and 2-months post-treatment to measure health-related quality of life and intervention satisfaction. In-depth interviews will be conducted with patients. Two focus groups will be conducted with MHP clinicians and CSC navigators to understand barriers and facilitators to the screening processes and intervention delivery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Positive screen (score >= 3 out of 8) on the anxiety or depression subscale of the CSS 15+ Questionnaire
- •PHQ-9 and/or GAD-7 score >= 5 at clinical intake
- •Willing to commit to the Meru Health Program if selected
- •Proficient in the English language
- •At least 18 years of age at the time of enrollment
- •Has a valid mailing address
- •Owns 1 of the 3 past versions of an Apple or Android mobile phone operating system
- •Currently in active cancer treatment at the time of enrollment
排除标准
- •Active suicide intent with plan to act
- •Substance use disorder in the past 3 months
- •Lifetime bipolar disorder
- •Lifetime psychotic disorder
- •Currently pregnant
- •Less than 3 months postpartum
结局指标
主要结局
Change in PHQ-9 Scores
时间窗: Baseline, Week 12, and 2 Month Follow-Up time points
9-item questionnaire to measure depression symptoms
Change in GAD-7 Scores
时间窗: Baseline, Week 12, and 2 Month Follow-Up time points
7-item questionnaire to measure anxiety symptoms
Change in Eurohis-QOL-8 Scores
时间窗: Baseline, Week 12, and 2 Month Follow-Up time points
8-item Quality of Life questionnaire.
Change in CSS 15+ Scores
时间窗: Baseline and Week 12 time points
15-item questionnaire to measure psychological distress experiencing and receiving treatment for cancer.
次要结局
- Change in Burnout Scores(Baseline, Week 12, and 2 Month Follow-Up)
研究者
Nicholas Peiper, PhD, MPH
Director of Research
Meru Health, Inc.